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Abstract
Operational tolerance is defined as stable renal function in
transplants without immunosuppression for at least 1 year.
We present histological assessments of two patients with
operational tolerance. The first withdrew immunosuppres-
sion in 2005 and presents stable renal function (creatinine
1.5 mg/dL) without proteinuria. The biopsy showed mild
chronic tubulointerstitial changes without inflammation.
The second withdrew immunosuppression in 2009 and
maintains stable renal function (creatinine 1.6 mg/dL) with
mild proteinuria. Histology showed chronic humoural re-
jection and Class II anti-human leukocyte antigen antibod-
ies were detected. These cases suggest that a renal biopsy
may be useful to rule out subclinical pathology in patients
with operational tolerance.
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Introduction
Renal transplantation requires life-long immunosuppres-
sion and despite the fact that new immunosuppressants
have allowed the acute rejection rate to be reduced, long-
term results have not clearly improved [1]. Thus, in order to
achieve tolerance, important resources have been focussed
on finding a strategy to overcome treatment complications
and chronic allograft dysfunction. Tolerance in renal trans-
plantation constitutes a very unusual circumstance de-
scribed in recipients of simultaneous renal and
haematopoietic cell transplantation or in a few treatment
non-compliant patients [2–9]. The very rare cases of toler-
ant renal transplants are actively sought to evaluate bio-
markers that can be employed to recognize cases that
might benefit from immunosuppression withdrawal [7, 9].
The term ‘operational tolerance’ has been coined as sta-
ble graft function in the absence of immunosuppression,
without markers of chronic rejection for>1 year. It has been
accepted that a serum creatinine <1.7 mg/dL and a protei-
nuria of <1 g/24 h constitute a reasonable threshold for the
absence of chronic rejection [6]. However, this definition is
imprecise and does not specify how to rule out signs of
chronic rejection. Accordingly, it is open to discussion
whether patients who have accomplished operational toler-
ance criteria should be biopsied to rule out subclinical path-
ology. In January 2009, we decided to biopsy patients who
had accomplished operational tolerance criteria after obtain-
ing informed consent. We report two cases with clinical
operational tolerance who were biopsied.
Patient 1
A male, born in 1934, with chronic renal failure of unknown
origin and on haemodialysis since 1980 received a deceased,
three human leukocyte antigen (HLA) mismatched and 60-
year-old kidney in 1984. He received azathioprine and pre-
dnisone and the clinical course was uneventful. In 1992, an
intestinal B-cell lymphoproliferative disorder was diagnosed.
Resection of a jejunal lesion was performed and six cycles of
chemotherapy (cyclophophamide, doxorubicin, vincristine
and prednisone) were administered. Azathioprine was with-
drawn and immunosuppression consisted of prednisone 10
mg/day. In 2001, an inguinal lymphadenopathy revealed a
relapse of the B-cell lymphoproliferative disorder. The pa-
tient declined chemotherapy and local radiotherapy was
performed. In 2004, he slowly reduced and spaced predni-
sone until complete withdrawal in 2005. Serum creatinine
remained stable and proteinuria was consistently <0.5 g/day.
In June 2010, the attending physician realized that the patient
was free of immunosuppression for 5 years. Serum creatinine
was 1.56 mg/dL and proteinuria 100 mg/24 h. Anti-HLA
antibodies were negative by solid-phase Luminex assay.
A surveillance biopsy was performed after receiving in-
formed consent. It contained six normal and two sclerosed
glomeruli. There was mild interstitial fibrosis and tubular
atrophy without interstitial infiltrating cells (Figure 1). The
arteries showed mild fibrous intimal thickening and the arte-
rioles showed mild hyaline changes. There was no glomer-
ulitis or peritubular capillaritis and C4d staining was
negative.
Patient 2
A male, born in 1974, with chronic renal failure due to
posterior urethral valves initiated haemodialysis in 1991.
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He received a deceased, three HLA mismatched and
17-year-old donor kidney in 1993. He was treated with
cyclosporine, azathioprine and prednisone. In 1998, aza-
thioprine was replaced by mycophenolate mofetil. In July
2008, he was admitted due to an acute rise in serum crea-
tinine from 1.5 to 4 mg/dL. He was empirically treated with
methylprednisolone boluses and serum creatinine returned
to 1.6 mg/dL. Before admittance for suspected acute rejec-
tion, serum creatinine had been continuously below
1.5 mg/dL with proteinuria <300 mg/day. The patient
was attended to until February 2009 when he was lost to
follow-up. In May 2010, he returned to the outpatient clinic
and serum creatinine was 1.6 mg/dL with proteinuria 500
mg/day. He admitted to irregular compliance with immu-
nosuppression before and after admittance for rejection and
complete withdrawal of immunosuppressants on April
2009. Anti-HLA Class I antibodies were negative, while
anti-HLA Class II antibodies were positive by solid-phase
Luminex assay.
The renal biopsy contained 23 glomeruli, of which 14
were sclerosed and 9 showed mesangial expansion. There was
a severe interstitial infiltrate with mild tubulitis (Figure 2).
Severe interstitial fibrosis and tubular atrophy were ob-
served. The arteries showed moderate intimal thickening
and there was moderate arteriolar hyalinosis. Transplant
glomerulopathy, moderate peritubular capillaritis and posi-
tive diffuse C4d staining were observed.
Discussion
We describe two patients who accomplished clinical opera-
tional tolerance criteria in whom a surveillance biopsy was
performed. In the first case, the biopsy was nearly normal
and the most remarkable finding was the absence of inflam-
mation. C4d staining and anti-HLA antibodies were nega-
tive. Lack of inflammation and signs of chronic humoural
rejection suggested true tolerance and immunosuppression
was not reintroduced. The second patient had been without
immunosuppression for 14 months. The biopsy showed
advanced chronic humoural rejection with C4d deposition
and anti-HLA Class II antibodies were detected. Despite
the fact that the presence of a late episode of acute rejection
may herald chronic rejection, this patient also accom-
plished operational tolerance criteria, and it should be taken
into consideration that a tolerant state has also been de-
scribed after acute rejection [6]. Thus, this case constitutes
an example, suggesting that clinical criteria may be insuf-
ficient to distinguish between tolerant and rejecting
patients.
Since surveillance biopsies have shown that histological
lesions may precede renal functional deterioration [10], it
seems reasonable that a proportion of patients who have
accomplished operational tolerance criteria may suffer
from subclinical pathology. However, mistaking chronic
humoural rejection for operational tolerance could imply
a significant risk for graft failure. In a study describing 10
patients with operational tolerance, two cases were biop-
sied for renal function deterioration [6]. In one patient,
there were no lesions of rejection, but the other one showed
C4d-negative transplant glomerulopathy after 7 years with-
out immunosuppression, raising the question whether a
surveillance biopsy would have allowed an earlier
diagnosis.
European and US Immune Tolerance Networks are look-
ing for patients with operational tolerance to characterize
biomarkers of this condition [9]. The few studied patients
who have accomplished these criteria have not been biop-
sied, and misclassification of even a few of them could
introduce a significant upheaval in the quest for a tolerant
signature.
In summary, we describe the biopsies of two patients
with clinical operational tolerance, showing normal histol-
ogy in the first one and chronic humoural rejection in the
second, suggesting that renal biopsy may be useful to rule
out subclinical conditions associated with shortened graft
survival.
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Fig. 1. Renal biopsy showing two normal glomerular sections: absence of
interstitial infiltrate and very mild interstitial expansion (haematoxylin and
eosin stain, 3200).
Fig. 2. Severe interstitial infiltrate with mild tubulitis and three sclerosed
glomerular sections (haematoxylin and eosin stain, 3100).
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